迪瑞医疗收盘下跌1.23%，滚动市盈率103.67倍，总市值37.11亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Dirui Medical, indicating a significant decline in revenue and profit in the latest quarterly report [1][2] - Dirui Medical's closing stock price is 13.61 yuan, with a PE ratio of 103.67, which is substantially higher than the industry average of 49.45 and the median of 35.92 [1][2] - The company has a total market capitalization of 3.711 billion yuan, ranking 106th in the medical device industry based on PE ratio [1][2] Group 2 - As of the first quarter of 2025, five institutions hold shares in Dirui Medical, with a total of 115.7415 million shares valued at 1.690 billion yuan [1] - The main business of Dirui Medical includes the research, production, marketing, and service of medical testing instruments and related reagents, with a total of 213 patents, including 136 invention patents [1] - The latest quarterly report shows that the company achieved an operating income of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.6787 million yuan, a year-on-year decrease of 87.13%, with a gross profit margin of 42.78% [1]